We are live on ! Find out more
GCM

Ghisallo Capital Management Portfolio holdings

AUM $3.63B
1-Year Est. Return 30.51%
This Fund
S&P 500
This Quarter Est. Return
+7.09%
1 Year Est. Return
+30.51%
3 Year Est. Return
+102.79%
5 Year Est. Return
+106.47%
10 Year Est. Return
AUM
$2.63B
AUM Growth
+$1.07B
Cap. Flow
+$1.01B
Cap. Flow %
38.55%
Top 10 Hldgs %
19.3%
Holding
550
New
313
Increased
8
Reduced
44
Closed
162

Sector Composition

Rank Sector Weight
1 Financials 22.77%
2 Technology 21.5%
3 Healthcare 14.71%
4 Consumer Discretionary 13.49%
5 Industrials 11.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CYT
376
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$535K 0.02%
+25,000
New +$468K
VTIQ
377
DELISTED
VectoIQ Acquisition Corp. II Class A Common Stock
VTIQ
$500K 0.02%
+50,000
New +$495K
CAHC
378
DELISTED
CA Healthcare Acquisition Corp. Class A Common Stock
CAHC
$495K 0.02%
+50,000
New +$494K
SLAC
379
DELISTED
Social Leverage Acquisition Corp I Class A Common Stock
SLAC
$486K 0.02%
+50,000
New +$488K
GLUE icon
380
Monte Rosa Therapeutics
GLUE
$1.35B
$454K 0.02%
+20,000
New +$407K
VOSO
381
DELISTED
Virtuoso Acquisition Corp. Class A Common Stock
VOSO
$397K 0.02%
+40,000
New +$391K
AKYA
382
DELISTED
Akoya BioSciences
AKYA
$387K 0.01%
+20,000
New +$413K
FRSG
383
DELISTED
First Reserve Sustainable Growth Corp. Class A Common Stock
FRSG
$364K 0.01%
+37,500
New +$366K
FTCI icon
384
FTC Solar
FTCI
$46.8M
$333K 0.01%
+2,500
New +$280K
OMIC
385
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$275K 0.01%
+333
New +$258K
BRNS
386
Barinthus Biotherapeutics
BRNS
$23M
$168K 0.01%
+10,000
New +$148K
ARYD
387
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
$161K 0.01%
15,000
TRML
388
DELISTED
Tourmaline Bio
TRML
$147K 0.01%
+1,000
New +$153K
BIDU icon
389
Baidu
BIDU
$37.1B
-479,447
Closed -$104M
GOTU icon
390
Gaotu Techedu
GOTU
$444M
-171,197
Closed -$5.8M
NBP
391
NovaBridge Biosciences American Depositary Shares
NBP
$205M
-420,675
Closed -$20.4M
PARA
392
DELISTED
Paramount Global Class B
PARA
-1,613,093
Closed -$72.8M
PSFE icon
393
Paysafe
PSFE
$366M
-125,000
Closed -$20.3M
QS icon
394
QuantumScape Corp
QS
$3.81B
-750,000
Closed -$33.6M
SMRT icon
395
SmartRent
SMRT
$261M
-100,000
Closed -$1M
JWSM.U
396
DELISTED
Jaws Mustang Acquisition Corp. Units, each consisting of one Class A ordinary share, and one-fourth of one redeemable warrant
JWSM.U
-764,434
Closed -$7.76M
PLMIU
397
DELISTED
Plum Acquisition Corp. I Units
PLMIU
-499,999
Closed -$4.97M
SLAMU
398
DELISTED
Slam Corp. Unit
SLAMU
-225,000
Closed -$2.23M
CVIIU
399
DELISTED
Churchill Capital Corp VII Units
CVIIU
-1,800,000
Closed -$17.9M
KRNLU
400
DELISTED
Kernel Group Holdings, Inc. Units
KRNLU
-397,500
Closed -$3.97M

Similar funds

Ghisallo Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Ghisallo Capital Management held 550 positions worth $2.63B, up 68% from $1.56B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Ghisallo Capital Management deployed $1.01B of net new capital in Q2 2021, opening 313 new positions and adding to 8 existing holdings. Its largest new stake was Keurig Dr Pepper: 2,000,000 shares worth $70.5M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, up from 7.6% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Zoom, an estimated $26.6M trimmed.

  • Ghisallo Capital Management's largest Q2 2021 buy was Keurig Dr Pepper: 2,000,000 shares worth $70.5M.
  • Ghisallo Capital Management added most to Leslie's in Q2 2021, an estimated $17.3M increase.
  • Ghisallo Capital Management's biggest Q2 2021 reduction was Zoom, cutting an estimated $26.6M.
  • Ghisallo Capital Management fully exited Baidu in Q2 2021, selling an estimated $104M.
  • Ghisallo Capital Management's ten largest holdings make up 19% of its $2.63B portfolio in Q2 2021.
  • Ghisallo Capital Management opened 313 new positions and closed 162 in Q2 2021.
  • Ghisallo Capital Management's portfolio value rose 68% quarter-over-quarter to $2.63B.

Based on Ghisallo Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.